Your browser version may not work well with NCBI's Web applications. More information here...
1: Clin Infect Dis. 2007 Mar 15;44(6):e67-8. Epub 2007 Feb 1.Click here to read Links

Prolonged QT interval and torsades de pointes associated with atazanavir therapy.

Ly T, Ruiz ME.

Department of Medicine, Washington Hospital Center, Washington, DC, USA.

We report, to our knowledge, the first documented case of torsades de pointes associated with atazanavir therapy. This case serves to highlight the need to monitor patients receiving atazanavir therapy who have risk factors for QT interval prolongation, such as female sex, bradycardia, electrolyte abnormalities, congestive heart failure, and a baseline prolonged QT interval.

PMID: 17304444 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Atazanavir (Reyataz® )

    Atazanavir is used in combination with other medications to treat human immunodeficiency virus (HIV) infection. Atazanavir is in a class of medications called HIV protease inhibitors. It works by slowing the spread of HI...

  • Source: AHFS Consumer Medication Information